Josefa Girona
0000-0002-6267-8779
Institut d'Investigació Sanitària Pere Virgili
75 papers found
Refreshing results…
The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
The apolipoprotein A5 gene –1131T→C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients
Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria
Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients
Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in Type 2 diabetes
Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit
Aldehydes mediate tissue factor induction: A possible mechanism linking lipid peroxidation to thrombotic events
HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages
Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease:
Impaired vitamin E status in patients with parenchymal liver cirrhosis: Relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma
Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice
Supplementation with Vitamin E and/or Zinc does not Attenuate Atherosclerosis in Apolipoprotein E-deficient Mice fed a High-Fat, High-Cholesterol Diet
2,4-decadienal downregulates TNF-α gene expression in THP-1 human macrophages
Missing publications? Search for publications with a matching author name.